Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News>This Article
  News
Return

e-Therapeutics Provides Update on Progress of ETS2101 Cancer Trials

Published: Monday, December 24, 2012
Last Updated: Monday, December 24, 2012
Bookmark and Share
Interim data from the trials are expected in H1 2013.


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Results from the Sidney Kimmel Cancer Center at Thomas Jefferson University
The Sidney Kimmel Cancer Center has published results of its work evaluating the potential for ANGLE’s Parsortix system.
Gene Variant Linked to Smoking Longer, Getting Lung Cancer Sooner
Smokers with a particular variation in a nicotine receptor gene were more likely to continue smoking for four years.
Scientists Discover Protein That Boosts Immunity to Viruses and Cancer
Researchers now developing a gene therapy designed to boost the infection-fighting cells.
NIH Study Finds Genetic Link for Rare Intestinal Cancer
Researchers recommend screening for people with family history.
Potential For Prediction Of Progression For Early Form Of Breast Cancer
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Understanding the Behaviour of Cells in Cancer Metastasis
LaVison BioTec report on the research of Professor Kurt I Anderson and his groups' studies of cell migration in the context of cancer metastasis at the Beatson Institute for Cancer Research.
Brain Tumor Weakness Identified
Discovery could offer a new target for treatment of glioblastoma.
Scientists Unveil Sex-Linked Control of Genes
Many proteins interact with an RNA molecule called Xist to coat and silence one X chromosome in every female cell.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters